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Abstract
Mitral valve regurgitation is a relatively common and important heart valve lesion in clinical practice
and adequate assessment is fundamental to decision on management, repair or replacement.
Disease localised to the posterior mitral valve leaflet or focal involvement of the anterior mitral
valve leaflet is most amenable to mitral valve repair, whereas patients with extensive involvement
of the anterior leaflet or incomplete closure of the valve are more suitable for valve replacement.
Echocardiography is the recognized investigation of choice for heart valve disease evaluation and
assessment. However, the technique is depended on operator experience and on patient's
hemodynamic profile, and may not always give optimal diagnostic views of mitral valve dysfunction.
Cardiac catheterization is related to common complications of an interventional procedure and
needs a hemodynamic laboratory. Cardiac magnetic resonance (MRI) seems to be a useful tool
which gives details about mitral valve anatomy, precise point of valve damage, as well as the quantity
of regurgitation. Finally, despite of its higher cost, cardiac MRI using cine images with optimized
spatial and temporal resolution can also resolve mitral valve leaflet structural motion, and can
reliably estimate the grade of regurgitation.
Introduction
The classical indications for surgical intervention of
patients with mitral regurgitation are based either on the
symptoms, or on the function of left ventricle and the esti-
mated degree of regurgitation in the non-symptomatic
patients [1]. According to the 2007 guidelines of Ameri-
can Heart Association [2] mitral valve (MV) surgery is rec-
ommended: 1. for symptomatic patients with acute severe
mitral regurgitation (MR). 2. MV surgery is beneficial for
patients with chronic severe MR and NYHA functional
class II, III, or IV symptoms in the absence of severe left
ventricle (LV) dysfunction (severe LV dysfunction is
defined as ejection fraction less than 0.30) and/or end-
systolic dimension greater than 55 mm. 3. MV surgery is
beneficial for asymptomatic patients with chronic severe
MR and mild to moderate LV dysfunction, ejection frac-
tion 0.30 to 0.60, and/or end-systolic dimension greater
than or equal to 40 mm. 4. MV repair is recommended
over MV replacement in the majority of patients with
severe chronic MR who require surgery, and patients
should be referred to surgical centers experienced in MV
repair [2]. In the cases of ischemic mitral regurgitation, the
decision to operate the mitral valve in combination with
bypass grafting is more difficult, and should generally be
made preoperatively. According to the ACC/AHA guide-
lines, it is indicated if the severity of regurgitation is char-
acterized "severe", namely 3+ or 4+, and also a significant
left ventricular dysfunction is evident [2]. Bolling S.
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reported in his article that a vicious cycle of continuing
volume overload, ventricular dilation, progression of
annular dilation, increased LV wall tension and worsening
MR and heart failure occur [3]. In other words, in every
case of mitral regurgitation, the indication for surgical
intervention is based on a reliable quantification of sev-
eral paraclinical methods. How reliable are these meth-
ods? Three are the methods of preoperative estimation of
mitral regurgitation: cardiac catheterization, Doppler
echocardiography and magnetic resonance imaging
(MRI). We would like to compare these diagnostic meth-
ods and the information which provide each of them to
cardiac surgeon.
A) Cardiac catheterization
Valvular regurgitation can be evaluated by angiography.
Angiographic evaluation of regurgitant severity is based
on ejection of contrast media into the left atrium, through
the affected mitral valve, or into the left ventricle through
the insufficient aortic valve [1]. The severity of regurgita-
tion is graded on a semi quantitative scale of 0+ to 4+ (see
table 1).
Severity of mitral valve regurgitation
It is evident from table 1, that the distinction between the
4 several grades of regurgitation are difficult and in most
cases inaccurate. This mode of estimation of degree of
regurgitation has some important limitations, which con-
futes its usefulness: a) the quantity of contrast material
(volume and speed of injection) is proportional of density
and if this is small may downregulate the grade of regur-
gitation [4,5], b) the arrhythmia (ventricular extra-beats
or atrial fibrillation, or even that produced by the catheter
itself) significantly affects the ventricular filling and sub-
sequently the indicated grade of regurgitation[5], c)
although mild regurgitation is clearly distinct from severe
regurgitation, intermediates grades may not be reliable
estimated [1], d) the position of catheter in the ventricle
(for mitral valve) or in the aorta (for aortic valve), in rela-
tion to the site of valve[5], e) the recorded plane of ventri-
cle and/or atrium, to avoid overlapping. The "ideal" plane
for estimation of aortic regurgitation is that of 45° in left
anterior oblique view with 10–15% of cranial angulation,
while that for mitral regurgitation is a 30° in right anterior
oblique view [1]. f) avoid the overlapping of descending
thoracic aorta and left atrium which may overestimate the
mitral regurgitation [1], g) avoid derangements of preload
and afterload (systemic and pulmonary vascular resist-
ance for aortic and mitral valve, respectively) which signif-
icantly affects the grade of regurgitation, h) the
coexistence of mitral and aortic regurgitation can change
the regurgitant contrast volume through the mitral valve
and therefore overestimates the grade of its regurgitation
[6]. According to Otto C [6], angiography offers evalua-
tion of grade of regurgitation only "in selected cases", and
especially when the non-invasive evaluation is inconso-
nant to the clinical findings. The advantages and disad-
vantages of angiography, Doppler and MRI are presented
in table 2.
Advantages and disadvantages of angiography, Doppler and MRI
Another significant component of estimation of valve
regurgitation is the calculation of regurgitant volume and
fraction. Regurgitant volume can be calculated by the for-
mula: regurgitant SV = total SV-forward SV, where total SV
is the total amount of ejected blood by the LV, measured
from left ventricular angiogram, and forward SV the
amount of blood ejected through the aortic valve, and
measured by Fick's thermodilution technique [6]. Accord-
ing to this equation, may be measured the regurgitation
fraction which characterizes the severity of valve regurgita-
tion: for < 20% mild, 20–40% moderate, 40–60% moder-
ately severe, and > 60% severe regurgitation [5].
Unfortunately, this method also has its limitations. First,
Table 1: Angiographic grading of regurgitant severity of aortic and mitral valve [1]. 
Grade Aortic regurgitation Mitral regurgitation
1+ Contrast refluxes from the aortic root into the left ventricle but 
clears on each beat
Contrast refluxes into the left atrium but clears on each beat
2+ Contrast refluxes into the left ventricle with a gradually 
increasing density of contrast in the left ventricle that never equals 
contrast intensity in the aortic root
Left atrial contrast density gradually increases but never equals 
left ventricle density
3+ Contrast refluxes into the left ventricle with a gradually 
increasing density such that left ventricle and aortic root density 
are equal after several beats
The density of contrast in the atrium and ventricle equalize after 
several beats
4+ Contrast fills the left ventricle resulting in an equivalent 
radiographic density in the left ventricle and aortic root on the 
first beat
The left atrium becomes as dense as the left ventricle on the first 
beat and contrast is seen refluxing into the pulmonary veins
The points of obscureness are in bold or with questionmarks.Journal of Cardiothoracic Surgery 2009, 4:34 http://www.cardiothoracicsurgery.org/content/4/1/34
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its accuracy is depended on the accuracy of measurements
of cardiac output [6], and second, in the case of coexist-
ence aortic and mitral regurgitation, only a rough estima-
tion of the portion of regurgitant fraction of each valve
can be made [6].
B) Doppler Echocardiography
Mitral regurgitation is a relatively common and important
heart valve lesion in clinical practice and adequate assess-
ment is fundamental to decisions on management.
Echocardiography is the recognized investigation of
choice for mitral valve regurgitation [7,8]. However, the
technique is operator dependent and may not always give
reliable diagnostic views for estimation of mitral valve
dysfunction. Transesophageal echocardiography, with 3-
dimentional visualization if available, generally gives a
better overall assessment of mitral valve dysfunction and
the lesions responsible for it, but is also operator depend-
ent, semi-invasive and usually requires patient's sedation
[9]. The latter may affect the quantity of mitral regurgita-
tion especially in the cases of ischemic origin. According
to Aklog L [10], 90% of their patients with moderate (3+/
4+) mitral regurgitation who underwent intraoperative
TEE had their MR downgraded to mild or less (1+-2+/4+),
and in 30% of their patients, there was no detectable MR
on intraoperative TEE. Similar results reported and other
studies concerning the influence of anaesthesia and seda-
tion on downgrading of real mitral regurgiration [11,12].
It is recognised that TEE assesses the mechanisms of valve
dysfunction well (leaflet prolapse/restriction) and is per-
haps the technique best able to determine the structural
lesion responsible for the incompetence (chordal/papil-
lary muscle rupture/elongation, leaflet perforation, etc).
Although TTE images using harmonic imaging can usually
identify leaflet abnormalities in mitral valve prolapse,
many patients will have poor image quality due to,
reduced ultrasound penetration through scar tissue, air
filled lung or excess adipose tissue [13]. Because of varia-
tion in image quality and imaging widows systematic seg-
mental mapping of the mitral valve leaflets is often not
attempted using 2-dimensional TTE in clinical practice.
The standard echocardiographic examination generally in
a valvular disease is based on Doppler colour flow imag-
ing, on pulsed Doppler transvalvular velocities, and on
continuous wave Doppler measures of regurgitant severity
[14]. Doppler colour flow imaging is used to estimate the
severity of aortic or mitral valve regurgitation. The amount
of regurgitant jet within the antecedent chamber (namely
LV for the aortic regurgitation and left atrium for the
mitral regurgitation), is directly proportional to the sever-
ity of valve regurgitation [15]. However, there are also
included some important limitations in this method: a) a
small degree of mitral and aortic valve regurgitation is
seen in 70–80%, and in 5–10% respectively, of normal
individuals [14], b) typically the size of the jet is indexed
to the size of the left atrium, and it is a drawback of this
method for precise estimation of mitral regurgitation [15].
C) The site of jet affects the measured grade of regurgita-
tion. Jets that are peripheral or impinging on a wall, rather
than centrally, cause underestimation of severity of regur-
gitation (of regurgitant volume) up to 40% [16,17].
Quantification of mitral regurgitation is also heavily
Table 2: Advantages and disadvantages of three methods of estimation of left-sided valve's regurgitation.
Mode of evaluation Advantages Disadvantages
Angiography -simultaneous calculation of SVR, PVR, LVEDP, PCWP, 
EF, etc (1,6)
-easy interpretation by cardiologists and cardiac 
surgeons (6)
-invasive method, risk of complications(5)
-misinterpretation in double valve disease (1,6)
-higher cost (5,6)
-temporarily affects hemodynamic of patient (SVR, PVR) and 
obscure the results (5)
-time-consuming
Doppler - non-invasive method
- no risks
- low-cost
- time-consuming
- does not affect hemodynamically the patient
- semi-quantitative
- overlapping structures
- "bad" window
- operator depending
discomfort+hemodynamic interaction of TEE – limitations 
(see text)
- influence of site of Jet
MRI - measurement of LVEDV, LVESV, LV mass
- no risk
- non invasive tool
- precise and valid estimation (23,24)
- does not need suppression or anaesthesia 
(such as TEE)
- estimation of myocardial function and viability (9,29)
- respiratory interference
-not-hemodynamic measurement
- not-anatomic information
- discomfort for the patient
- artefacts in the case of metallic materials (40,41)
(SVR: systemic venous resistance, PVR: pulmonary venous resistance, PCWP: pulmonary capillary wedge pressure, EF: enjection fraction, LVEDV: 
left ventricle end diastolic volume), LVESV: left ventricle end systolic volume, LV mass: left ventricle mass, TEE: Transesophageal echocardiography).Journal of Cardiothoracic Surgery 2009, 4:34 http://www.cardiothoracicsurgery.org/content/4/1/34
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dependent on the colour Doppler flow area, and pertains
to the holosystolic regurgitation [15]. The criteria of char-
acterization of severity of mitral regurgitation are included
in the table 3.
Criteria of characterization of severity of mitral regurgitation
It is obvious from table 3: a) that the distinction between
mild and severe grade of regurgitation by using the
method is easy, but not for the intermediate (II and III)
grades, and b) the measurement all of above mentioned
parameters of Doppler ECHO is dependent on many oth-
ers hemodynamic paramenters such as the preload, after-
load, and rhythm [14], anatomic parameters such as the
dimensions of left atrium [15], or on technical parameters
such the "window" [14], as well as on other parameters
such as operator's experience, ability of device, etc. For
these reasons, interpretation of colour flow data is quite
variable, with a disagreement of 29% for aortic and 25%
for mitral regurgitation [14,18].
There are also some others proposed semi-quantitave
mitral regurgitation indices, such as a scoring system of
severity, with included most of parameters of table 3, and
scored each of them between 0 and 3 [17,19]. According
to this system, the total score is divided through the
number of evaluated parameters, and for index > 2.2 indi-
cates a severe regurgitation, > 1.7 a mild, and index from
1.7 to 2.2 indicate an intermediate or better, vague estima-
tion of regurgitation. However, and this method has the
same limitations which reported earlier, plus that of val-
ues approximation (methodological problems).
According to Loick et al [20], the intraoperative echocardi-
ographic assessment of mitral regurgitation is reliable,
simple and relatively unaffected by hemodynamics. It
means that in the one side, it may be involved fewer
imponderable factors, but on the other side, it may not be
acceptable from a surgical point of view, because it may
underestimate the grade of regurgitation [14,20,21].
The regurgitant volume is estimated by using the proximal
isovelocity surface area (PISA) on colour Doppler imaging
[22,23]. This measurement has also several important
limitations such as the integration of diastolic flow, as
well as caveats of used mathematic types [14].
C) Magnetic Resonance Imaging
Magnetic Resonance Imaging is a third method for estima-
tion (quantification) of mitral valve regurgitation. The
assessment is based on estimation of regurgitant volume
by determining the difference between the stroke volumes
of ventricles [24]. Stroke volumes are calculated from a
stack frame of images as the difference between and-
diastolic and end-systolic volumes for each ventricle [24].
In the normal individuals, stroke volume of right ventricle
is nearly equivalent to that of left ventricle. Every differ-
ence between the two measured stroke volumes indicates
the amount of blood which comes back through the
insufficient valve during diastole. The estimation is pre-
cise, but the limitations of method are the following: a)
the measurement is reliable only for the case of single
regurgitant valve; in the cases of combined aortic and
mitral regurgitation, the difference represents the sum of
regurgitant volume [23]. b) The estimation is valid, only
if the tricuspid valve is sufficient [23,24]. Another method
for quantification of valve regurgitation is the cine MRI
[24,25]. Especially for the aortic valve, this method can
discriminate between antegrade and retrograde flow dur-
ing the cardiac cycle by analysis of bright or dark voxels in
the ascending aorta, enabling retrograde flow to be
directly measured [24,26]. Diastolic retrograde aortic flow
equals aortic regurgitant volume, and correlates closely
with volumetric cine MRI [23,24].
Table 3: The severity of mitral regurgitation according to the Doppler echocardiography ([15]
Severity Of Mitral Valve Regurgitation I (mild) II III IV (severe)
Jet (% Left atrium) < 15% 15–30% 35–50% > 50%
Spectral Doppler Faint --Dense
Vena contracta < 3 mm - - > 6 mm
Pulmonary vein flow S > D - - Systolic reversed
Right ventricle (ml) < 30 30–45 45–59 > 60
Effective regurgitant orifice (ERO in cm2) < 0.20 0.20–0.29 0.30–0.39 > 40
Proximal Isovelosity Surface Area (PISA) small --large
The points of inaccuracy are depicted in bold or with question marks.Journal of Cardiothoracic Surgery 2009, 4:34 http://www.cardiothoracicsurgery.org/content/4/1/34
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According to Kizilbash et al [27], the MRI provides accu-
rate measurements of regurgitant flow that correlate well
with quantitative Doppler imaging, and in addition, it is
the most accurate non-invasive technique for measuring
ventricular end-diastolic volume, end-systolic volume
and left ventricular mass. Concerning the estimation of
mitral regurgitation MRI in the last years is considered
more reliable in comparison to these of echocardiogra-
phy. In fact, there are many studies comparing the two
methods [7,8]. Cardiovascular MRI has many advantages
like accurate determination of left as well as right ventricu-
lar volumes and function [28,29], measurements of aortic
flow volume, and in ischemic mitral regurgitation, com-
prehensive assessment of regional myocardial function
and viability [28,30]. When used optimally, MRI can com-
plement echocardiography in the assessment of mitral
regurgitation, especially in patients in whom transtho-
racic echocardiography has not provided adequate infor-
mation [9]. Finally, MRI has been proved that overtake the
limitations of ecocardiography (overlapping structures,
"bad window", artefacts, or contraindications of TEE. On
the other hand, in its limitations are included the respira-
tion, and the higher cost [7].
The mitral regurgitant volume (MRV) measured by MRI is
the difference between the LV stroke volume (LVSV) and
the aortic forward stroke volume (AoSV) i.e. MRV (mls/
beat) = LVSV – AoSV. The regurgitant fraction (RF) is the
ratio of the MRV divided by the LVSV i.e. RF (%) = (MRV
× LVSV) × 100 [9].
It may also be possible to directly measure mitral inflow
volume by phase-contrast velocity flow mapping at the
tips of the mitral valve leaflets but this requires a special-
ised imaging sequence which tracks the motion of the
mitral valve annulus during the cardiac cycle [31]. In the
absence of other regurgitant lesions, MRV can also be cal-
culated by subtracting the right ventricle stroke volume
(RVSV) from the LVSV i.e. MRV = LVSV – RVSV, using
established techniques [28]. However, the calculation of
RVSV is less reproducible compared to LVSV due to the
extensive trabeculation of the right ventricle (RV). Moreo-
ver, associated tricuspid regurgitation is reported in up to
50% of patients with significant mitral regurgitation and
this invalidates the use of RVSV to determine MRV [32].
The American College of Cardiology [2,8] has established
echocardiographic criteria for grading the severity of
mitral regurgitation. In the absence of established criteria
for MRI, the findings of this study, derived from LV vol-
ume and ascending aortic flow measurements, can be
noted: mild = RF ≤ 15%, moderate = RF 16–24%, moder-
ate-severe = RF 25–42%, severe = RF > 42%.
A further feature of severe mitral regurgitation is reversal
of flow in the pulmonary veins during LV systole, which
may be visible in the 4 chamber and certain mitral stack
cines [9].
Evaluation of mitral valve dysfunction from standard,
routinely acquired MRI imaging planes alone is rarely ade-
quate. The proposed technique by Kim RJ et al [9], with
additional imaging of the mitral valve based on its anat-
omy, allows more detailed evaluation of its dysfunction.
In degenerative valve disease, MRI allows determination
of the leaflet scallop, responsible for the valve dysfunction
e.g. P2 or P3 prolapse, and hence helps guide surgical
repair. In rheumatic valve disease, ÌRI allows assessment
of the severity of valve restriction and hence helps deter-
mine the feasibility of valve repair and the need for valve
replacement. In functional mitral regurgitation due to
ischemic heart disease or cardiomyopathy, it confirms the
diagnosis and helps exclude coexisting degenerative valve
disease. Comparison of the accuracy and reproducibility
of MRI using this technique with echocardiography, espe-
cially transesophageal echocardiography, and findings at
surgery will need to be done. Two recent studies using
similar techniques as described here, but without the
additional slices taken at the commissural ends of the
mitral valve, have recently been published [33,34]. The
first study reported a sensitivity and specificity of 89% and
88% respectively for detecting flail or prolapsed leaflets
compared to findings at surgery in 47 patients. This com-
pared with a sensitivity and specificity of 93% and 88%
respectively for transesophageal echocardiography [33].
The second study reported agreement between CMR
assessment and transthoracic echo determination of pro-
lapsed or flail leaflets in 92% of 27 patients [33]. Accord-
ing to the lattest study, there was an excellent concordance
between MRI and transthoracic echocardiography in the
identification of jet direction and leaflet abnormality. MRI
mapping of the mitral valve using a simple protocol can
reliably acquire long axis images through the valve, facili-
tating localisation of leaflet abnormalities and regurgitant
jet direction. When compared to modern TTE, the MRI
mapping protocol accurately identified the abnormal leaf-
let in 98% of cases [34]. The difference between the 2 tech-
niques was differentiating leaflet flail from prolapse in 3
patients and MRI failing to detect a borderline prolapse (2
mm) involving an anterior mitral valve leaflet. Using
either technique, variation in defining the border between
adjacent leaflet segments (e.g. A1 from A2) can lead to
minor differences in classification but is less likely to
effect the decision for valve repair versus replacement. The
presence of a flail mitral valve leaflet identifies patients
who are at a higher risk of sudden cardiac death and may
warrant early surgery if the valve is repairable [35]. The
discrepancies in classification of prolapse and flail seg-
ments may also in part be due to superior spatial resolu-
tion of echocardiographic over MRI when there areJournal of Cardiothoracic Surgery 2009, 4:34 http://www.cardiothoracicsurgery.org/content/4/1/34
Page 6 of 7
(page number not for citation purposes)
adequate echocardiographic windows. MRI spatial resolu-
tion is dependent on the voxel size and the slice thickness
of the planes used. Hence, visualising the direction of the
mitral valve leaflet tip (1 – 5 mm thickness dependent on
the degree of mitral leaflet thickening) to define segment
prolapse versus flail may be difficult. In addition, insuffi-
cient contrast between the signal loss defining the origin
of the regurgitant jet and the distal mitral leaflet tip may
contribute to the minor differences seen. An advantage of
MRI compared to TTE is that because there is no limita-
tion of imaging windows the MRI mapping protocol ena-
bled a complete and systematic assessment of the mitral
valve in every patient. Acquisition of the mapping images
is usually efficient, requiring on average 7 cine images,
and between 5 to 10 minutes per patient. MRI is an accu-
rate, reproducible, and non-invasive manner, potentially
enabling better estimation of the timing and type of surgi-
cal intervention. Cine MRI is a highly sensitive diagnostic
tool to assess changes in LV mass and volume [36-39].
This is supported by Bottini et al. They showed that MRI is
the most precise method for measuring LV mass when
compared to Transthoracic echocardiography in hyper-
tensive patients [40], suggesting that for more specific
questions MRI may be the more reliable imaging tool.
Francois et al. have shown that MRI assessment of LV mass
correlated well with true LV mass measurements during
autopsy [41]. However, MRI is expensive, time-consum-
ing, and only available in specialized centers and there-
fore no alternative for routine patient follow-up in smaller
hospitals and private practices.
Conclusion
In patients with mitral valve regurgitation MRI has an
established role in the assessment of LV size and function
and mitral regurgitation severity. With the addition of
mitral valve mapping, MRI can potentially provide a com-
prehensive assessment of mitral regurgitation. Compre-
hensive assessment of mitral regurgitation requires
assessment of: (a) its severity to determine the need for
surgical intervention, (b) the mechanism of the dysfunc-
tion to determine the type of surgical intervention
required (leaflet prolapse/restriction, including the leaflet
scallops involved: A1-P1, A2-P2, A3-P3); (c) LV volumes
and function to determine the timing and risks of surgery;
and, in ischemic mitral regurgitation, (d) LV viability.
Such comprehensive assessment is feasible in a single MRI
examination but needs a defined protocol, as described in
this paper. When used optimally, MRI can complement
existing imaging modalities such as echocardiography in
the assessment of patients with mitral regurgitation. The
fixed imaging planes of MRI and its suboptimal through-
plane resolution rarely permit adequate visualisation of
the chordal structures to identify rupture or elongation
accurately. MRI is also not suited for visualisation of leaf-
let and annular calcification which are important factors
influencing the probability of successful valve repair. MRI,
when used optimally, may therefore play a useful role in
assessing the mitral valve in patients in whom transtho-
racic echocardiography has not provided adequate imag-
ing and in whom transesophageal echocardiography is
considered too invasive.
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